In March 2006, Dr. Mendell injected the first U.S. investigational gene therapy for Duchenne muscular dystrophy into the arm muscle of a young boy with DMD. That boy was Andrew Kilbarger. The injection, using an adeno-associated virus (AAV)-mediated vector, delivered microdystrophin to the muscle producing a functional protein that reduced muscle deterioration. “Andrew is so important because his injections proved the safety and efficacy of this therapy,” Dr. Mendell explains. Today, we unite in the fight against Duchenne muscular dystrophy. The strength and resilience of Andrew Kilbarger and Dr. Mendell and his team represents a beacon of hope, saving lives and paving the way for a brighter future. To learn more about Duchenne and get involved, visit https://buff.ly/3yZ1G7r #AndelynBiosciences #DuchenneMuscularDystrophy #WDAD2024
Andelyn Biosciences
Biotechnology Research
Columbus, Ohio 7,853 followers
Accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients.
Über uns
Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope into Reality™. Our capabilities span viral vector process and analytical development, adherent and suspension based GMP drug substance manufacturing up to 2,000L, as well as GMP plasmid process development and GMP manufacturing. We are located in Columbus, OH, USA. With more than 20 years of pioneering experience in viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with extensive expertise. We have produced GMP material for over 75 worldwide clinical trials in addition to over 450 cGMP clinical batches and more than 2,000 research-grade productions. Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Our 180,000 sq ft clinical and commercial manufacturing facility comprises 16 upstream production suites for customization of new and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.
- Website
-
http://www.AndelynBio.com
External link for Andelyn Biosciences
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Columbus, Ohio
- Typ
- In Privatbesitz
- Gegründet
- 2020
- Spezialitäten
- Biotechnology, Pharmaceuticals, Gene Therapy, Biological Sciences, Research, and CDMO
Standorte
-
Primäre
1180 Arthur E. Adams Dr.
Columbus, Ohio 43221, US
Employees at Andelyn Biosciences
Aktualisierungen
-
Andelyn Biosciences reposted this
At Andelyn Biosciences, we believe in the power of experience, know-how, and precision. Our modern facilities, designed for today’s highest quality rigor, and team of seasoned scientists are at the forefront of AAV gene therapy, offering reliable expertise in process development and cGMP manufacturing. Start working with us with a small-scale feasibility study and generate the data to drive decisions for your critical roadmap to clinical and commercial manufacturing. Learn more about our feasibility study offer here https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO
-
-
Andelyn Biosciences collaborates closely with you throughout the development process to establish a dependable and high quality clinical and commercial material. We support you at every step. Learn more about our viral vector manufacturing: https://buff.ly/4dHYV9K #AndelynBiosciences #GeneTherapy #ViralVectorManufacturing
-
-
Andelyn Biosciences reposted this
The path to advancing healthcare through gene therapy is both exciting and complex. At Andelyn Biosciences, we’re not just part of this journey; we’re leading the way with expertise and reliable manufacturing. Whether you are in need of tech transferring the manufacturing of your program or looking for development and scale up into Andelyn’s AAV Curator™ Platform, let us work together to shape a hopeful future for patients in need of life-altering therapies. Learn more about our feasibility studies as a first step into a partnership defined by expertise and close collaboration. https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO #AAVCuratorPlatform
-
-
Andelyn Biosciences reposted this
Our journey began at Nationwide Children's Hospital, leading to the discovery of the first FDA-approved systemic gene therapy. Today, we stand ready as your reliable partner, equipped with the expertise and scalable solutions to bring your therapies from concept to commercialization. Get in touch and discover how we can contribute to your long-term success with a low risk feasibility study: https://buff.ly/3UzqzNP #andelynbiosciences
-
-
With over 20 years of experience in cell and gene therapy manufacturing, Andelyn understands how plasmids can impact vector packaging performance. Through a close collaboration between the plasmid and vector teams, clients can leverage our extensive expertise for vector design consultation and optimization. Learn more about our plasmid manufacturing: https://buff.ly/3WUPVqG #AndelynBiosciences #GeneTherapy #PlasmidManufacturing
-
-
Andelyn Biosciences reposted this
Andelyn Biosciences is excited to announce we are hosting an Inaugural Golf Tournament on September 30, 2024 at The Country Club at Muirfield Village. Join us FORE One Purpose to raise both awareness and funds for the gene therapy and rare disease community we support. Learn more about how you can participate here: https://lnkd.in/gRQSMnst #andelynbiosciences #genetherapy
-
-
Andelyn Biosciences reposted this
In an industry where change is ever constant, Andelyn Biosciences stands as your steadfast partner in gene therapy manufacturing. With over two decades of experience and expertise, our commitment to growth and innovation ensures we're here for you, ready to bring your groundbreaking therapies from the lab to the patient. See what a feasibility study and yield assessment can do to get your program started on a path to process industrialization: https://buff.ly/3UzqzNP #andelynbiosciences
-
-
Andelyn Biosciences supports clients from preclinical concept to commercialization. We have supported more than 75 INDs with successful completion of over 450 cGMP clinical batches and over 2,000 research grade batches. Head to our website to learn about all of our capabilities: https://lnkd.in/ep8wf7ma #AndelynBiosciences #CDMO #GeneTherapy https://lnkd.in/eNwkza4x
Cell and Gene Therapy CDMO Andelyn Biosciences
https://www.youtube.com/
-
Are you in need of finding a home for the manufacturing of your AAV Program? Decades of AAV experience and production data allows us to know which process parameter and manufacturing technology levers to pull to quickly optimize your process. Through Optimization-By-Design™ we strike the right balance between yield and purity for the advancement of your program. Learn more about our feasibility studies as a first step into a partnership defined by expertise and trust: https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO
-